Accumulation of Fluconazole in Scalp Hair
- 1 February 1998
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 38 (2) , 138-143
- https://doi.org/10.1002/j.1552-4604.1998.tb04402.x
Abstract
The accumulation in scalp hair of the antimycotic triazole, fluconazole, was studied during and after administration. Fluconazole 50 mg was administered to 12 healthy subjects as a single capsule each day for 28 days. The concentration of fluconazole 5 hours after administration was measured in different 1-cm sections of scalp hair at intervals during treatment and for 6 months after the end of treatment. In each section of scalp hair the concentration of fluconazole increased during treatment and was consistently higher than values found in plasma. For example, the mean concentration in the first hair section on day 28, 19.8 μg/g, corresponded to a mean penetration ratio relative to plasma of 9.42. During administration, the maximal concentration of fluconazole was found in the first hair section. After cessation of administration, the measured concentrations of fluconazole decreased and greater concentrations were found in the distal hair sections, presumably as a result of hair growth. Fluconazole was detectable, however, in the hair of 9 of the 12 subjects even 6 months after treatment. The mean concentration of fluconazole in hair bulbs on day 28 was 12.1 μg/g (n = 6), corresponding to a mean penetration ratio of 5.99. In a second study, fluconazole was administered as a single oral 150-mg capsule per week for 4 weeks to a group of 8 healthy subjects. The mean fluconazole concentration in whole scalp hair 5 hours after the last dose was 3.2 μg/g.Keywords
This publication has 21 references indexed in Scilit:
- Efficacy and Safety of Oral Fluconazole in the Treatment of Patients with Tinea Corporis, Cruris or Pedis or Cutaneous CandidosisClinical Drug Investigation, 1996
- FluconazoleDrugs, 1995
- An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancyAnnals of Hematology, 1995
- Tinea capitis: Epidemiology, diagnosis, treatment, and controlJournal of the American Academy of Dermatology, 1994
- Bioavailability of fluconazole in the skin after oral medicationMycoses, 1994
- Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis/cruris and cutaneous candidiasisClinical and Experimental Dermatology, 1992
- Fluconazole in the treatment of onychomycosis caused by dermatophytesJournal of Dermatological Treatment, 1992
- Treatment of kerion with fluconazoleThe Lancet, 1991
- FluconazoleDrugs, 1990
- SPECIAL SYMPOSIAPediatric Dermatology, 1985